HUGO urges genetic benefit-sharing

Area of Science:

• Bioethics
• Genomic Research Ethics
• Global Health Equity

Background:

• For-profit genetic research funding surpasses public investment.
• Potential for Human Genome Project benefits to disproportionately favor wealthy nations and individuals.
• Ethical considerations surrounding equitable access to genetic research advancements.

Purpose of the Study:

• To discuss the necessity and framework for benefit-sharing in genetic research.
• To address challenges in defining 'community' for benefit-sharing, particularly with multifactorial diseases.
• To explore ethical arguments and practical recommendations for equitable distribution of genomic research benefits.

Main Methods:

• Deliberations by the HUGO Ethics Committee.
• Analysis of case examples from single-gene to multi-factorial disorders.
• Discussion of ethical principles including common heritage, common resource, and types of justice (compensatory, procedural, distributive).

Main Results:

• Acknowledged difficulties in defining community, especially for multifactorial diseases.
• Affirmed the ethical arguments for benefit-sharing based on shared heritage and resources.
• Highlighted the importance of community participation in defining benefits.

Conclusions:

• Companies in the health sector have obligations beyond taxation regarding genetic research.
• Recommended that health companies allocate 1-3% of net profits towards healthcare infrastructure or humanitarian initiatives.
• Emphasized the need for equitable benefit-sharing to ensure broader societal gains from genetic research.